Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles

BACKGROUND: Cholangiocarcinoma (CCA) is a rare disease, but it is amongst the most lethal cancers with a median survival under 1 year. Variations in DNA methylation and gene expression have been extensively studied in other cancers for their role in pathogenesis and disease prognosis, but these stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Nitish Kumar, Niu, Meng, Southekal, Siddesh, Bajpai, Prachi, Elkholy, Amr, Manne, Upender, Guda, Chittibabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606733/
https://www.ncbi.nlm.nih.gov/pubmed/33193605
http://dx.doi.org/10.3389/fgene.2020.522125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606733/
https://www.ncbi.nlm.nih.gov/pubmed/33193605
http://dx.doi.org/10.3389/fgene.2020.522125

Ejemplares similares